CLINICAL_TRIALS
trial_result
· 2021-04-09
Clinical Trial Update: Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer [Phase 2]
Summary
Phase II trial evaluating temsirolimus as a second-line therapy in relapsed bladder cancer has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Institut Bergonié | Conditions: Relapsed Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-04-09